- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 10 granted · 30 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2382 | MediWound Ltd. | — | $31M |
| 2383 | SALIX PHARMACEUTICALS LTD | — | $750M |
| 2384 | Stemsynergy Therapeutic | — | — |
| 2385 | HiberCell | — | — |
| 2386 | RaeSedo, LLC | — | — |
| 2387 | Rakuten Medical, Inc. | — | $887M |
| 2388 | Avalo Therapeutics | — | $182M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- GCN2 Inhibitor For Treating Metastasesapplication
- Perk Inhibiting Compoundsgranted
- GCN2 Modulator For Treating Cancerapplication
- Methods For Identifying Beta-glucan Binding To Immune Cellsgranted
- Perk Inhibiting Imidazolopyrazine Compoundsgranted
- Beta-glucan In Combination With Anti-cancer Agents Affecting The Tumor Micrenvironmentapplication
- Beta-glucan Methods And Compositions That Affect The Tumor Microenvironmentapplication
- Beta-glucan Immunotherapies Affecting The Immune Microenvironmentapplication
- Beta-glucan In Combination With Anti-cancer Agents Affecting The Tumor Microenvironmentapplication
- Aminopyrimidine Derivatives As Phosphatidylinositol Phosphate Kinase Inhibitorsgranted
- Aminopyridine Derivatives As Phosphatidylinositol Phosphate Kinase Inhibitorsapplication
- GCN2 Modulating Compounds And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.